Publications

Cellular oncology (Dordrecht, Netherlands)

Disconnect between in vitro and in vivo efficacy of the MPS1 inhibitor NTRC 0066-0 against glioblastoma.

16-02-2026

International journal of cancer

Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway.

15-02-2026

International journal of cancer

Cause-specific mortality after a diagnosis of ductal carcinoma in situ: Associations with screening and socio-economic status.

15-02-2026

Therapeutic drug monitoring

Impact of Abiraterone Therapeutic Drug Monitoring on Cortisol as a Surrogate Biomarker of CYP17 Inhibition in Metastatic Prostate Cancer Treatment.

13-02-2026

Journal of experimental & clinical cancer research : CR

Tertiary lymphoid structures in the era of cancer therapy.

11-02-2026

RSC chemical biology

Identification of mono-ADP-ribose readers using well-defined photoaffinity-based probes.

11-02-2026

PloS one

Patients' and relatives' perspectives on the quality of end-of-Life care in advanced cancer: From the final months to bereavement.

09-02-2026

Cancer discovery

Mind the GARP: How Glucocorticoids Unleash T Cells against Melanoma.

06-02-2026

Science (New York, N.Y.)

Synergy between regulatory elements can render cohesin dispensable for distal enhancer function.

05-02-2026

Nature communications

NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy.

05-02-2026

The oncologist

Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis.

05-02-2026

Breast (Edinburgh, Scotland)

Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: a population-based study including 121347 patients.

01-02-2026

European urology oncology

Novel Molecular Biomarkers to Guide Treatment Decision-making in Metastatic Urothelial Cancer-A Patient Cohort Analysis.

01-02-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors.

01-02-2026

Oncogene

MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumors.

01-02-2026

Clinical pharmacokinetics

Population Pharmacokinetics of Total and Protein-Unbound Prednisolone in Children with Immune-Mediated and Systemic Inflammatory Diseases.

01-02-2026

Journal of cancer survivorship : research and practice

Eight-year follow-up of patient-reported outcomes in patients with breast cancer participating in exercise studies during chemotherapy.

01-02-2026

Biomedical chromatography : BMC

An Overview of Liquid Chromatography-Mass Spectrometry (LC-MS) Methods for the Quantification of Antibody-Drug Conjugates.

01-02-2026

Breast (Edinburgh, Scotland)

Eligibility for bilateral prophylactic mastectomy: An expert opinion study in the Netherlands.

01-02-2026

The American journal of surgical pathology

Performance Assessment of a Deep Learning-based Algorithm for Ovarian Cancer Histotyping in an Independent Data Set.

01-02-2026

Annals of surgical oncology

Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.

01-02-2026

JAMA otolaryngology-- head & neck surgery

Patient-Reported Outcomes Across Treatment Strategies in Papillary Thyroid Microcarcinoma: A Meta-Analysis.

01-02-2026

JAMA oncology

Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens.

01-02-2026

Molecular oncology

Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities.

01-02-2026

Lymphatic research and biology

Lymphatic Drainage of the Abdominal Wall Within the Extended Nodal Dissection Template During Prostate Cancer Surgery-Mapping Overlapping Patterns.

01-02-2026

Breast (Edinburgh, Scotland)

Divergence of DNA tumor mutations in cerebrospinal fluid in metastatic breast cancer patients with leptomeningeal metastases.

01-02-2026

Journal of magnetic resonance imaging : JMRI

Assessing Quality and Adherence to PI-RADSv2.1 Minimum Technical Standards of Prostate MRI in NRG-GU005.

01-02-2026

Nature cell biology

Structural organization and function of telomeric chromatin.

01-02-2026

Trends in immunology

Epigenetically programmed identity crisis to combat diffuse large B cell lymphoma.

01-02-2026

Molecular oncology

Strength through diversity: how cancers thrive when clones cooperate.

01-02-2026

Computer methods and programs in biomedicine

Explainable feature selection combining particle swarm optimisation with adaptive LASSO for MRI radiogenomics: Predicting HPV status in oropharyngeal cancer.

01-02-2026

Molecular biology of the cell

The RhoGEF Trio regulates the formation of tensile linear endothelial junctions to improve barrier function.

01-02-2026

Clinical pharmacology and therapeutics

Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing.

01-02-2026

European radiology

Diagnostic accuracy of CT for identifying high-risk colon cancer: a systematic review and meta-analysis.

01-02-2026

Nature reviews. Immunology

Lessons from neoadjuvant immunotherapy in melanoma: understanding antitumour immunity and tumour escape.

01-02-2026

Trends in cancer

The evolving landscape of brain metastasis: volume II.

01-02-2026

Breast (Edinburgh, Scotland)

Outcomes for ER-positive CHEK2 c.1100delC breast cancer patients compared with breast cancer patients without the variant.

01-02-2026

Annals of oncology : official journal of the European Society for Medical Oncology

Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma.

01-02-2026

Breast (Edinburgh, Scotland)

The trajectory of fatigue over time in breast cancer patients treated with chemotherapy: exploring the effect of anthracycline-based chemotherapy.

01-02-2026

Journal of cancer survivorship : research and practice

Prevalence and determinants of sleep problems in cancer survivors compared to a normative population: a PROFILES registry study.

01-02-2026

Nature

Author Correction: PHGDH heterogeneity potentiates cancer cell dissemination and metastasis.

01-02-2026

Breast cancer research : BCR

One size does not fit all: data-driven insights of patient-reported outcomes to tailor supportive care in breast cancer.

30-01-2026

NPJ precision oncology

Multi-omics deep learning improves FDG PET-CT-based long-term prognostication of breast cancer.

29-01-2026

Breast cancer research and treatment

Dual-modality breast cancer screening compared to MRI or mammography alone among female Hodgkin lymphoma survivors who received chest radiotherapy.

28-01-2026

Cell reports

Aneuploidy patterns in colorectal cancer.

27-01-2026

Journal of experimental & clinical cancer research : CR

CRISPR knockout screens reveal JUN as the master mediator of resistance to MAPK inhibition in KRAS-mutant pancreatic cancer.

22-01-2026

Nature communications

Meta-unstable mRNAs in activated CD8⁺ T cells are defined by interlinked AU-rich elements and m⁶A mRNA methylation.

22-01-2026

Communications biology

MHC1-TIP enables single-tube multimodal immunopeptidome profiling and uncovers intratumoral heterogeneity in antigen presentation.

22-01-2026

Cancers

Understanding the Experiences of Adolescents and Young Adults Diagnosed with Cancer During Higher Education-An Exploratory Interview Study.

20-01-2026

Cell reports. Medicine

CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance.

20-01-2026

Disconnect between in vitro and in vivo efficacy of the MPS1 inhibitor NTRC 0066-0 against glioblastoma.

Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway.

Cause-specific mortality after a diagnosis of ductal carcinoma in situ: Associations with screening and socio-economic status.

Impact of Abiraterone Therapeutic Drug Monitoring on Cortisol as a Surrogate Biomarker of CYP17 Inhibition in Metastatic Prostate Cancer Treatment.

Tertiary lymphoid structures in the era of cancer therapy.

Identification of mono-ADP-ribose readers using well-defined photoaffinity-based probes.

Patients' and relatives' perspectives on the quality of end-of-Life care in advanced cancer: From the final months to bereavement.

Mind the GARP: How Glucocorticoids Unleash T Cells against Melanoma.

Synergy between regulatory elements can render cohesin dispensable for distal enhancer function.

NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy.

Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis.

Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: a population-based study including 121347 patients.

Novel Molecular Biomarkers to Guide Treatment Decision-making in Metastatic Urothelial Cancer-A Patient Cohort Analysis.

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors.

MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumors.

Population Pharmacokinetics of Total and Protein-Unbound Prednisolone in Children with Immune-Mediated and Systemic Inflammatory Diseases.

Eight-year follow-up of patient-reported outcomes in patients with breast cancer participating in exercise studies during chemotherapy.

An Overview of Liquid Chromatography-Mass Spectrometry (LC-MS) Methods for the Quantification of Antibody-Drug Conjugates.

Eligibility for bilateral prophylactic mastectomy: An expert opinion study in the Netherlands.

Performance Assessment of a Deep Learning-based Algorithm for Ovarian Cancer Histotyping in an Independent Data Set.

Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.

Patient-Reported Outcomes Across Treatment Strategies in Papillary Thyroid Microcarcinoma: A Meta-Analysis.

Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens.

Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities.

Lymphatic Drainage of the Abdominal Wall Within the Extended Nodal Dissection Template During Prostate Cancer Surgery-Mapping Overlapping Patterns.

Divergence of DNA tumor mutations in cerebrospinal fluid in metastatic breast cancer patients with leptomeningeal metastases.

Assessing Quality and Adherence to PI-RADSv2.1 Minimum Technical Standards of Prostate MRI in NRG-GU005.

Structural organization and function of telomeric chromatin.

Epigenetically programmed identity crisis to combat diffuse large B cell lymphoma.

Strength through diversity: how cancers thrive when clones cooperate.

Explainable feature selection combining particle swarm optimisation with adaptive LASSO for MRI radiogenomics: Predicting HPV status in oropharyngeal cancer.

The RhoGEF Trio regulates the formation of tensile linear endothelial junctions to improve barrier function.

Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing.

Diagnostic accuracy of CT for identifying high-risk colon cancer: a systematic review and meta-analysis.

Lessons from neoadjuvant immunotherapy in melanoma: understanding antitumour immunity and tumour escape.

The evolving landscape of brain metastasis: volume II.

Outcomes for ER-positive CHEK2 c.1100delC breast cancer patients compared with breast cancer patients without the variant.

Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma.

The trajectory of fatigue over time in breast cancer patients treated with chemotherapy: exploring the effect of anthracycline-based chemotherapy.

Prevalence and determinants of sleep problems in cancer survivors compared to a normative population: a PROFILES registry study.

Author Correction: PHGDH heterogeneity potentiates cancer cell dissemination and metastasis.

One size does not fit all: data-driven insights of patient-reported outcomes to tailor supportive care in breast cancer.

Multi-omics deep learning improves FDG PET-CT-based long-term prognostication of breast cancer.

Dual-modality breast cancer screening compared to MRI or mammography alone among female Hodgkin lymphoma survivors who received chest radiotherapy.

Aneuploidy patterns in colorectal cancer.

CRISPR knockout screens reveal JUN as the master mediator of resistance to MAPK inhibition in KRAS-mutant pancreatic cancer.

Meta-unstable mRNAs in activated CD8+ T cells are defined by interlinked AU-rich elements and m6A mRNA methylation.

MHC1-TIP enables single-tube multimodal immunopeptidome profiling and uncovers intratumoral heterogeneity in antigen presentation.

Understanding the Experiences of Adolescents and Young Adults Diagnosed with Cancer During Higher Education-An Exploratory Interview Study.

CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance.

This site uses cookies

Meta-unstable mRNAs in activated CD8⁺ T cells are defined by interlinked AU-rich elements and m⁶A mRNA methylation.